Murphy S. ABO blood groups and platelet transfusion. Transfusion 1988;28:401–2.10.1046/j.1537-2995.1988.28588337323.xSearch in Google Scholar
Aster RH. Effect of anticoagulant and ABO incompatibility on recovery of transfused human platelets. Blood 1965;26:732–43.10.1182/blood.V26.6.732.732Search in Google Scholar
Herman JH. Apheresis platelet transfusions: does ABO matter? Transfusion 2004;44:802–4.10.1111/j.1537-2995.2004.44601.xSearch in Google Scholar
Benjamin RJ, Antin JH. ABO-incompatible bone marrow transplantation: the transfusion of incompatible plasma may exacerbate regimen-related toxicity. Transfusion 1999;39:1273–4.10.1046/j.1537-2995.1999.39111273.xSearch in Google Scholar
Lapierre V, Mahe C, Auperin A, et al. Platelet transfusion containing ABO-incompatible plasma and hepatic veno-occlusive disease after hematopoietic transplantation in young children. Transplantation 2005;80:314–9.10.1097/01.tp.0000167758.63247.f4Search in Google Scholar
Mollicone R, Caillard T, Pendu JL, et al. Expression of ABH and X (LeX) antigens on platelets and lymphocytes. Blood 1988;71:1113–9.10.1182/blood.V71.4.1113.1113Search in Google Scholar
Santoso S, Kiefel V, Mueller-Eckhardt C. Blood group A and B determinants are expressed on platelet glycoproteins IIa, IIIa, and Ib. Thromb Haemostasis 1991;65:196–201.10.1055/s-0038-1647483Search in Google Scholar
Stockelberg D, Hou M, Rydberg L, Kutti J, Wadenvik H. Evidence for an expression of blood group A antigen on platelet glycoproteins IV and V. Transfus Med 1996;6:243–8.10.1111/j.1365-3148.1996.tb00075.xSearch in Google Scholar
Kelton JG, Smith JW, Horsewood P, et al. ABH antigens on human platelets: expression on the glycosyl phosphatidylinositol-anchored protein CD109. J Lab Clin Med 1998;132:142–8.10.1016/S0022-2143(98)90009-9Search in Google Scholar
Cooling LLW, Kelly K, Barton J, et al. Determinants of ABH expression on human blood platelets. Blood 2005;105:3356–64.10.1182/blood-2004-08-308015613545Search in Google Scholar
Tsuji T, Osawa T. Structures of the carbohydrate chains of membrane glycoproteins IIb and IIIa of human platelets. J Biochem 1986;100:1387–98.10.1093/oxfordjournals.jbchem.a121845Search in Google Scholar
Julmy F, Achermann F, Schulzki T, Carrel T, Nydegger U. Platelets of blood group A1 donors express increased surface A antigen owing to apheresis and prolonged storage. Transfusion 2003;43:1378–85.10.1046/j.1537-2995.2003.00526.xSearch in Google Scholar
Devine V, Thon J, Schubert P, Serrano K, Kast J. Application of proteomics methods to the analysis of the platelet storage lesion. Vox Sang 2006; 91(Suppl 3): S34.Search in Google Scholar
Kelton JG, Hamid C, Aker S, Blajchman M. The amount of blood group A substance on platelets is proportional to the amount in the plasma. Blood 1982;59:980.10.1182/blood.V59.5.980.980Search in Google Scholar
Dunstan RA, Mansbach CM. Biochemical characterization of A blood group activity on human platelets. Vox Sang 1985;49:149–53.10.1111/j.1423-0410.1985.tb00783.xSearch in Google Scholar
Holgersson J, Breimer ME, Jacobsson A, et al. Glycolipid- and glycoprotein-based blood group A antigen expression in human thrombocytes. A1/A2 difference. Glycoconjugate J 1990;7:601–8.10.1007/BF01189080Search in Google Scholar
Koerner TAW, Weinfeld HM, Bullard LSB, Williams LCJ. Antibodies against platelet glycosphingolipids: detection in serum by quantitative HPTLC-autoradiography and association with autoimmune and alloimmune processes. Blood 1989; 74:274–84.10.1182/blood.V74.1.274.274Search in Google Scholar
Cooling LLW, Zhang D, Koerner TAW. Human platelets express gangliosides with LKE activity and ABH blood group activity. Transfusion 2001;41:504–16.10.1046/j.1537-2995.2001.41040504.xSearch in Google Scholar
Holgersson J, Breimer ME, Samuelsson BE. Basic biochemistry of cell surface carbohydrates and aspects of the tissue distribution of histo-blood group ABH and related glycosphingolipids. APMIS Suppl 1992;27:18–27.Search in Google Scholar
Stults CL, Sweeley CC, Macher BA. Glycosphingolipids: structure, biological source, and properties. Methods Enzymol 1989;179:167–214.10.1016/0076-6879(89)79122-9Search in Google Scholar
Dunstan RA, Simpson MB, Knowles RW, Rosse WF. The origin of ABH antigens on human platelets. Blood 1985;65:615–9.10.1182/blood.V65.3.615.615Search in Google Scholar
Cao Y, Merling A, Karsten U, Schwartz-Albiez R. The fucosylated histo-blood group antigen H (type 2 blood group O, CD173) and Lewis Y (CD174) are expressed on CD34+ hematopoietic progenitors but absent on mature lymphocytes. Glycobiology 2001;11:677–83.10.1093/glycob/11.8.67711479278Search in Google Scholar
Hosoi E, Hirose M, Hamano S. Expression levels of H-type (1,2)-fucosyltransferase gene and histoblood group ABO gene corresponding to hematopoietic cell differentiation. Transfusion 2003;43:65–71.10.1046/j.1537-2995.2003.00277.xSearch in Google Scholar
Okumura M, Morishima Y, Michinori O, et al. Expression of H-related antigen on human megakaryocytes and megakaryocytic leukemic cells. Int J Hematol 1991;54:151–8.Search in Google Scholar
Schmitz B, Thiele J, Otto F, et al. Interactions between endogenous lectins and fucosylated oligosaccharides in megakaryocyte-dependent fibroblast growth of the normal bone marrow. Leukemia 1996;10:1604–14.Search in Google Scholar
Sweegman S, Veenhof MA, Huijgens PC, Schuurhuis GJ, Drager AM. Regulation of megakaryocytopoiesis in an in vitro stroma model: preferential adhesion of megakaryocytic progenitors and subsequent inhibition of maturation. Exp Hematol 2000;28:401–10.10.1016/S0301-472X(00)00128-4Search in Google Scholar
Han P, Guo XH, Story CJ. Enhanced expansion and maturation of megakaryocytic progenitors by fibronectin. Cytotherapy 2002;4:277–83.10.1080/146532402320219790Search in Google Scholar
Mossuz P, Schweitzer A, Molla A, Berthier R. Expression and function of receptors for extracellular matrix molecules in the differentiation of human megakaryocytes in vitro. Br J Haematol 1997;98:819–27.10.1046/j.1365-2141.1997.3013118.xSearch in Google Scholar
Molla A, Mossuz P, Berthier R. Extracellular matrix receptors and the differentiation of human megakaryocytes in vitro. Leuk Lymphoma 1999;33:15–23.10.3109/10428199909093721Search in Google Scholar
Ichikawa D, Handa K, Hakomori SI. Histo-blood group A/B antigen deletion/reduction vs. continuous expression in human tumor cells as correlated with their malignancy. Int J Cancer 1998;76:284–9.10.1002/(SICI)1097-0215(19980413)76:2<284::AID-IJC17>3.0.CO;2-CSearch in Google Scholar
Ichikawa D, Handa K, Withers DA, Hakomori SI. Histo-blood group A/B versus H status of human carcinoma cells as correlated with haptotactic cell motility: approach with A and B gene transfection. Cancer Res 1997;57:3092–6.Search in Google Scholar
Groupille C, Marionneau S, Bureau V, et al. 1,2-fucosyltransferase increases resistance to apoptosis of rat colon carcinoma cells. Glycobiology 2000;10:375–82.10.1093/glycob/10.4.375Search in Google Scholar
Hoffman S, Zhou L, Gu Y, Davenport R, Cooling L. Delayed platelet engraftment in group O patients after autologous progenitor cell transplantation. Transfusion 2005;45:885–95.10.1111/j.1537-2995.2005.04346.xSearch in Google Scholar
Skogen B, Rossenbo Hansen B, Husebekk A, Havnes T, Hannestad K. Minimal expression of blood group A antigen on thrombocytes from A2 individuals. Transfusion 1988;28:456–9.10.1046/j.1537-2995.1988.28588337336.xSearch in Google Scholar
Curtis BR, Edwards JT, Hessner MJ, Klein JP, Aster RH. Blood group A and B antigens are strongly expressed on platelets of some individuals. Blood 2000;96:1574–81.10.1182/blood.V96.4.1574Search in Google Scholar
Heal JM, Mullin A, Blumberg N. The importance of ABH antigens in platelet crossmatching. Transfusion 1989;29:514–20.10.1046/j.1537-2995.1989.29689318450.xSearch in Google Scholar
Ogasawara K, Ueki J, Takenaka M, Furihata K. Study on the expression of ABH antigens on platelets. Blood 1993;82:993–9.10.1182/blood.V82.3.993.993Search in Google Scholar
Jimenez TM, Patel SB, Pineda AA, Tefferi A, Owen WG. Factors that influence platelet recovery after transfusion: resolving donor quality from ABO compatibility. Transfusion 2003;43:328–34.10.1046/j.1537-2995.2003.00326.xSearch in Google Scholar
Heal JM, Blumberg N, Masel D. An evaluation of crossmatching, HLA, and ABO matching for platelet transfusions to refractory patients. Blood 1987;70:23–30.10.1182/blood.V70.1.23.23Search in Google Scholar
Schlichter SJ, Davis K, Enright H, et al. Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients. Blood 2005;105:4106–14.10.1182/blood-2003-08-2724Search in Google Scholar
Brand A, Sintnicolaas K, Claas FH, Eernisse JG. ABH antibodies causing platelet transfusion refractoriness. Transfusion 1986;26:463–6.10.1046/j.1537-2995.1986.26587020127.xSearch in Google Scholar
Friedberg RC, Donnelly SF, Boyd JC, Gray LS, Mintz PD. Clinical and blood bank factors in the management of platelet refractoriness and alloimmunization. Blood 1993;81:3428–34.10.1182/blood.V81.12.3428.3428Search in Google Scholar
Lee EJ, Schiffer CA. ABO compatibility can influence the results of platelet transfusion. Transfusion 1989;29:384–9.10.1046/j.1537-2995.1989.29589284135.xSearch in Google Scholar
Carr R, Hutton JL, Jenkins JA, Lucas GF, Amphlett NW. Transfusion of ABO-mismatched platelets leads to early platelet refractoriness. Br J Haematol 1990;75:408–13.10.1111/j.1365-2141.1990.tb04356.xSearch in Google Scholar
Ishibashi M, Oshida M, Kurata Y, et al. Immunologic low-responder in ABO-incompatible renal transplant recipients explored by donor-specific platelet transfusion. Transplant Proc 1998;30: 2298–9.10.1016/S0041-1345(98)00629-0Search in Google Scholar
Heal JM, Masel D, Blumberg N. Interaction of platelet Fc and complement receptors with circulating immune complexes involving the ABO system. Vox Sang 1996;71:205–11.10.1159/000462059Search in Google Scholar
Heal JM, Masel D, Rowe JM, Blumberg N. Circulating immune complexes involving the ABO system after platelet transfusion. Br J Haematol 1993;566–72.10.1111/j.1365-2141.1993.tb03349.xSearch in Google Scholar
Duquesnoy RJ, Anderson AJ, Tomasulo PA, Aster RH. ABO compatibility and platelet transfusions of alloimmunized thrombocytopenic patients. Blood 1979;54:595–9.10.1182/blood.V54.3.595.595Search in Google Scholar
Ellinger PJ, Morgan LK, Malecek AC, Chaplin H. Effect of ABO mismatching on a radioimmunoassay for platelet compatibility. Successful adsorption of ABO alloantibodies with synthetic A and B substance. Transfusion 1989;29:134–8.10.1046/j.1537-2995.1989.29289146831.xSearch in Google Scholar
Blumberg N, Heal JM, Rapoport A, et al. Effect of ABO-identical platelets and leukodepletion on blood utilization and costs of autologous marrow transplantation (abstract). Transfusion 1993;33: A15.Search in Google Scholar
Heal JM, Rowe JM, Blumberg N. ABO and platelet transfusion revisited. Ann Hematol 1993;66: 309–14.10.1007/BF01695973Search in Google Scholar
Blumberg N, Heal JM, Kirkley SA, et al. Leukodepleted-ABO identical blood components in the treatment of hematologic malignancies: a cost analysis. Am J Hematol 1995;48:108–15.10.1002/ajh.2830480208Search in Google Scholar
Heal JM, Kenmotsu N, Rowe JM, Blumberg N. A possible survival advantage in adults with acute leukemia receiving ABO-identical platelet transfusions. Am J Hematol 1994;45:189–90.10.1002/ajh.2830450219Search in Google Scholar
Heal JM, Blumberg N. Optimizing platelet transfusion therapy. Blood Rev 2004;18:149–65.10.1016/S0268-960X(03)00057-2Search in Google Scholar
Blumberg N, Heal JM, Hicks GL, Risher WH. Association of ABO-mismatched platelet transfusions with morbidity and mortality in cardiac surgery. Transfusion 2001;41:790–3.10.1046/j.1537-2995.2001.41060790.x11399821Search in Google Scholar
Blumberg N, Heal JM. ABO-mismatched platelet transfusions and clinical outcomes after cardiac surgery (letter). Transfusion 2002;42:1527–9.10.1046/j.1537-2995.2002.00263.x12421232Search in Google Scholar
Lin Y, Callum JL, Coovadia AS, Murphy PM. Transfusion of ABO-nonidentical platelets is not associated with adverse clinical outcomes in cardiovascular surgery patients. Transfusion 2002;42:166–72.10.1046/j.1537-2995.2002.00037.x11896330Search in Google Scholar
Badros A, Tricot G, Toor A, et al. ABO mismatch may effect engraftment in multiple myeloma patients receiving nonmyeloablative conditioning. Transfusion 2002;42:205–9.10.1046/j.1537-2995.2002.00027.x11896336Search in Google Scholar
Benjamin RJ, McGurk S, Ralston MS, Churchill WH, Antin JH. ABO incompatibility as an adverse risk factor for survival after allogeneic bone marrow transplantation. Transfusion 1999;39:179–87.10.1046/j.1537-2995.1999.39299154733.x10037129Search in Google Scholar
Stussi G, Halter J, Schanz U, Seebach JD. ABO-histo blood group incompatibility in hematopoietic stem cell and solid organ transplantation. Transfus Apheresis Sci 2006;35:59–69.10.1016/j.transci.2006.05.00916935028Search in Google Scholar
Brecher ME, ed. Technical manual, 15th ed. Bethesda, MD: American Association of Blood Banks, 2005.Search in Google Scholar
Gordon B, Tarantolo S, Ruby E, et al. Increased platelet transfusion requirement is associated with multiple organ dysfunctions in patients undergoing hematopoietic stem cell transplantation. Bone Marrow Transplant 1998;22: 999–1003.10.1038/sj.bmt.17014649849698Search in Google Scholar
West L, Pollock-Barziv SM, Diphanc AI, et al. ABO-incompatible heart transplantation in infants. N Engl J Med 2001;344:793–800.10.1056/NEJM20010315344110211248154Search in Google Scholar
Stegall MD, Dean PG, Gloor JM. ABO-incompatible kidney transplantation. Transplantation 2004;78: 635–40.10.1097/01.TP.0000136263.46262.0DSearch in Google Scholar
Zoes C, Dube VE, Miller HJ, Vye MV. Anti-A1 in the plasma of platelet concentrates causing a hemolytic reaction. Transfusion 1977;17:29–32.10.1046/j.1537-2995.1977.17177128880.x841668Search in Google Scholar
McLeod BC, Sassetti RJ, Weens JH, Vaithianathan T. Haemolytic transfusion reaction due to ABO incompatible plasma in a platelet concentrate. Scand J Haematol 1982;28:193–6.10.1111/j.1600-0609.1982.tb00514.x7089480Search in Google Scholar
Conway LT, Scott EP. Acute hemolytic transfusion reaction due to ABO incompatible plasma in a platelet apheresis concentrate (letter). Transfusion 1984;24:413–4.10.1046/j.1537-2995.1984.24585017836.x6485086Search in Google Scholar
Pierce RN, Reich LM, Mayer K. Hemolysis following platelet transfusions from ABO-incompatible donors. Transfusion 1985;25:60–2.10.1046/j.1537-2995.1985.25185116506.xSearch in Google Scholar
Ferguson DJ. Acute intravascular hemolysis after a platelet transfusion. Can Med Assoc J 1988;138: 523–4.Search in Google Scholar
Reis MD, Coovadia AS. Transfusion of ABO-incompatible platelets causes severe haemolytic reaction. Clin Lab Haematol 1989;11:237–40.10.1111/j.1365-2257.1989.tb00214.xSearch in Google Scholar
Murphy MF, Hook S, Waters AH, et al. Acute haemolysis after ABO-incompatible platelet transfusions (letter). Lancet 1990;335:974–5.10.1016/0140-6736(90)91040-HSearch in Google Scholar
Chow M-P, Yung C-H, Hu H-Y, Tzeng C-H. Hemolysis after ABO-incompatible platelet transfusion. Chin Med J (Taipei) 1991;48:131–4.Search in Google Scholar
Mair B, Benson K. Evaluation of changes in hemoglobin levels associated with ABO-incompatible plasma in apheresis platelets. Transfusion 1998;38:51–5.10.1046/j.1537-2995.1998.38198141498.xSearch in Google Scholar
McManigal S, Sims KL. Intravascular hemolysis secondary to ABO incompatible platelet products. Am J Clin Pathol 1999;111:202–6.10.1093/ajcp/111.2.202Search in Google Scholar
Duguid JKM, Minards J, Bolton-Maggs PHB. Lesson of the week: incompatible plasma transfusions and haemolysis in children. Br Med J 1999;318: 176–7.10.1136/bmj.318.7177.176Search in Google Scholar
Larsson LG, Welsh VJ, Ladd DJ. Acute intravascular hemolysis secondary to out-of-group platelet transfusion. Transfusion 2000;40:902–6.10.1046/j.1537-2995.2000.40080902.xSearch in Google Scholar
Valbonesi M, De Luigi MC, Lercari G, et al. Acute intravascular hemolysis in two patients transfused with dry-platelet units obtained from the same ABO incompatible donor. Int J Artif Organs 2000;23:642–6.10.1177/039139880002300908Search in Google Scholar
Sauer-Heilborn A, Jahagirdar B, Burns L, Scofield T, Nollet KE. Passive antibody, aggressive hemolysis: an ABO-incompatible platelet transfusion (abstract). Transfusion 2002;42(Suppl): SP304.Search in Google Scholar
Reducing supernatant plasma of pooled platelets before administration to ABO-incompatible recipients. CBBS, e-network forum. Available at: http:// www.cbbsweb.org/enf/2002/pltpoolplasma.html.Search in Google Scholar
Gresens C, Gloster E, Wang L, Dimaio T. Acute hemolysis in a group A trauma patient who received a group O plateletpheresis unit (abstract). Transfusion 2003;43(Suppl): SP234.Search in Google Scholar
Yeast JD, Plapp F. Fetal anemia as a response to prophylactic platelet transfusion in the management of alloimmune thrombocytopenia. Am J Obstet Gynecol 2003;189:874–6.10.1067/S0002-9378(03)00229-1Search in Google Scholar
Ozturk A, Turken O, Sayan O, Atasoyu EM. Acute intravascular hemolysis due to ABO-incompatible platelet transfusion. Acta Haematol 2003;110: 211–2.10.1159/00007423014663170Search in Google Scholar
What is the frequency of hemolytic reactions associated with transfusion of plateletpheresis units containing ABO incompatible plasma. CBBS, e-network forum. Available at: http://www. cbbsweb.org/enf/2003/plt_aborxnfreq.html.Search in Google Scholar
Josephson CD, Mullis NC, Van Demark C, Hillyer CD. Significant numbers of apheresis-derived group O platelet units have “high-titer” anti-A/A, B: implications for transfusion policy. Transfusion 2004;44:805–8.10.1111/j.1537-2995.2004.03290.x15157243Search in Google Scholar
Angiolillo A, Luban NLC. Hemolysis following an out-of-group platelet transfusion in an 8-month-old with Langerhans cell histiocytosis. J Pediatr Hematol Oncol 2004;26:267–9.10.1097/00043426-200404000-0001215087958Search in Google Scholar
Sapatnekar S, Sharma G, Downes KA, Wiersma S, McGrath C, Yomtovian R. Acute hemolytic transfusion reaction in a pediatric patient following transfusion of apheresis platelets. J Clin Apheresis 2005;20:225–9.10.1002/jca.2007216265630Search in Google Scholar
Sadani DT, Urbaniak SJ, Bruce M, Tighes JE. Repeat ABO-incompatible platelet transfusions leading to haemolytic transfusion reaction. Transf Med 2006;16:375–9.10.1111/j.1365-3148.2006.00684.x16999762Search in Google Scholar
Lozano M, Cid J. The clinical implications of platelet transfusions associated with ABO or Rh(D) incompatibility. Transfus Med Rev 2003;17: 57–68.10.1053/tmrv.2003.5000312522772Search in Google Scholar
Pietersz RNI, Engelfriet CP. Transfusion of apheresis platelets and ABO groups. Vox Sang 2005;88: 207–21.10.1111/j.1423-0410.2005.00615.x15787735Search in Google Scholar
Schwartz J, Delpalma H, Kapoor K, Hamilton T, Grima K. Anti-A titers in group O single donor platelets: to titer or not to titer (abstract). Transfusion 2003;43(Suppl): SP247.Search in Google Scholar
Oza KK. ABO mismatched platelet transfusion and acute intravascular hemolysis (abstract). Transfusion 2002;42(Suppl): SP308.Search in Google Scholar
Wagner F, Adamo W. Reduced rate of adverse reactions to plasma reduced pooled platelet units: possible role of minor incompatible transfusion (abstract). Vox Sang 2006;91(Suppl 3): P508.Search in Google Scholar
Shanwell A, Ringden O, Wiechel B, Rumin S, Akerblom O. A study of the effect of ABO incompatible plasma in platelet concentrates transfused to bone marrow transplant recipients. Vox Sang 1991;60:23–7.10.1159/000461242Search in Google Scholar
Mollison PL, Engelfriet CP, Contreras M, ed. Blood transfusion in clinical medicine. 10th ed. Oxford: Blackwell Science, 1997.Search in Google Scholar
Boothe G, Brecher ME, Root M, Robinson J, Haley R. Acute hemolysis due to passively transfused high-titer anti-B causing spontaneous in vitro agglutination. Immunohematology 1995;11:43–5.10.21307/immunohematology-2019-786Search in Google Scholar
The practice of transfusing out-of-type platelets. CBBS, e-network forum. Available at: http://www. cbbsweb.org/enf/2002/plttx_aboincompat.html.Search in Google Scholar
de Wildt-Eggen J, Gulliksson H. In vivo and in vitro comparison of platelets stored in either synthetic media or plasma. Vox Sang 2003;84:256–64.10.1046/j.1423-0410.2003.00303.x12757499Search in Google Scholar
Ringwald J, Zimmerman R, Eckstein R. The new generation of platelet additive solution for storage at 22°C: development and current experience. Transfus Med Rev 2006;20:158–64.10.1016/j.tmrv.2005.11.00316565028Search in Google Scholar
de Wildt-Eggen J, Nauta S, Schrijver JG, van Marwijk Kooy M, Bins M, van Prooijen HC. Reactions and platelet increments after transfusion of platelet concentrates in plasma or an additive solution: a prospective, randomized study. Transfusion 2000;40:398–403.10.1046/j.1537-2995.2000.40040398.x10773049Search in Google Scholar
References on patient outcomes following transfusion of ABO incompatible platelets. CBBS, e-network forum. Available at: http//www. cbbsweb.org/enf/outcome_aboinc_plt.html.Search in Google Scholar
Chambers LA. Transfusion of plasma and platelets to neonates. In: Herman JH, Manno CS, eds. Pediatric transfusion therapy, 2002. Bethesda, MD: AABB Press, 2002:93–107.Search in Google Scholar
